Efficacy of Transcutaneous nerve mapping in treatment of Meralgia Paresthetica.

Comparison of the efficacy of Lateral Femoral Cutaneous Nerve Block using Ultrasound alone or in combination with Transcutaneous Nerve Mapping in Meralgia Paresthetica.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046479

Enrollment

Registered

2022-10-14

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Lateral Femoral Cutaneous Nerve Block: under ultrasound guidance compared with double confirmation via transcutaneous nerve mapping (10 - 15 min) Control Intervention1: Lateral Femoral

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA Grade 1 and 2 2. weight from 35 Kg to 70 Kg

Exclusion criteria

Exclusion criteria: 1.Lumbosacral Spine Pathologies 2. Cardiovascular and Neurological Diseases 3. Uncontrolled diabetes 4. Pregnancy 5. Known allergy to the interventional drugs i.e. local anaesthetics, steroids

Design outcomes

Primary

Measure	Time frame
Neuropathic Pain Symptom Inventory (NPSI) scoreTimepoint: Prior, 1 hour, 4 hours, 1 week, 2 weeks, 4 weeks	—

Secondary

Measure	Time frame
1. To evaluate patientâ??s relief in terms of Global Pain Scale (GPS) scoring. 2. Requirement of rescue analgesics on weekly basis 3. Complication, such as pain, bleeding, infection or any other, occurring during and after the injection shall be noted. Timepoint: GPS score before and 4 weeks after intervention. Number of times rescue analgesics taken. Pain, Bleeding, Hematoma.	—

Countries

India

Contacts

Public ContactHammad Usmani

Jawaharlal Nehru Medical College and Hospital, AMU

hammadusmani2002@gmail.com9897114190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026